Skip to main content

Unilever to go further green

Consumer products giant Unilever has announced plans to source all of the carbon-based materials in its cleaning and laundry products from renewable or recycled sources, thus throwing down the gauntlet to chemical suppliers.  According to Unilever, this will cut the carbon footprint of its product formulations by up to 20%, since the chemicals it uses in cleaning and account for 46% – of that footprint. The company’s most famous brands include Persil, Omo, Domestos, Cif and Sunlight.

Evonik acquires Porocel Group

Evonik has acquired the Porocel Group, which has developed a technology for the rejuvenation of desulfurisation catalysts in a $210 million deal. This deal is scheduled to close by the end of 2020, subject to regulatory approval.

Executive board chairman Christian Kullmann commented: “This acquisition is the next logical step in the strategic development of our portfolio. Our focus is on stable and high-margin speciality chemicals.”

Personal care materials from CO2

Skin care giant Beiersdorf and Evonik have agreed a research partnership to develop sustainable raw materials for personal care products via artificial photosynthesis, using CO2 as the starting material, along with water, solar energy and bacteria. The two companies described this part of their ongoing efforts to reduce their carbon footprints and becoming carbon-positive.  

Evonik expands in pharma in Germany

Evonik, which is one of the world’s largest pharmaceutical CDMOs, has announced the €25 million first stage of a long-term programme to expand API and advanced intermediates capacity at its sites in Dossenheim and Hanau, Germany. This should be completed by mid-2021 and the whole project should be finalised prior to 2024.

Evonik acquires InnoHealth

Evonik has acquired Spain’s InnovativeHealth Group (InnoHealth) on undisclosed terms and incorporated it into the Care Solutions business line.

Evonik closes PeroxyChem buy

Evonik has closed the $640 million acquisition of PeroxyChem from One Equity Partners, after a lawsuit to block it filed by the Federal Trade Commission in August 2019 was rejected.

ROMEO, ROMEO...

Evonik and nine partners in the ROMEO (Reactor Optimisation by Membrane-Enhanced Operation) project have succeeded in developing catalysing oxo reactions, in which olefins are converted into aldehydes with synthesis gas in a hydroformylation reaction.
Subscribe to Evonik

 

 

 

AMRI banner advert